உ டிரான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Lee University s LEAP Welcomes 20 Incoming Freshmen
chattanoogan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chattanoogan.com Daily Mail and Mail on Sunday newspapers.
Go1 raises $200M at a $1B+ valuation to boost its curated enterprise learning platform – TechCrunch
techcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcrunch.com Daily Mail and Mail on Sunday newspapers.
Brisbane s Go1 becomes Australia s newest billion-dollar start-up
afr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from afr.com Daily Mail and Mail on Sunday newspapers.
Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers
ACCESSWIRE
13 May 2021, 22:05 GMT+10
Havn Life to supply naturally-derived psilocybin to ATMA Journey Centers in Alberta and Nicoya Peninsula, Costa Rica
VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP)(the Company or Havn Life ), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce it has entered into a supply agreement (the Supply Agreement ) with ATMA Journey Centers Inc. - an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally - to be their exclusive supplier of naturally-derived psilocybin.
MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors
News provided by
Share this article
Share this article
ATMA Was The First Private Sector Service Provider In Canada Conducting Legal Psychedelic-Assisted Therapy For A Palliative Care Patient Under The Approval Of Health Canada s Section 56(1) Exemption
VANCOUVER, BC, April 8, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( MINDCURE or the Company ) a leader in advanced proprietary technology for psychedelic therapy, is pleased to announce a further strategic equity investment in